Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether pharmacogenomic study of bioamine
transporters and peripheral lymphatic biomarkers(phenotype) predict antidepressant
responsiveness in advance before the appearance of the drug effects until 4~6 weeks after
drug administration.